During the last session, Mirum Pharmaceuticals Inc (NASDAQ:MIRM)’s traded shares were 0.74 million, with the beta value of the company hitting 0.95. At the end of the trading day, the stock’s price was $50.34, reflecting an intraday loss of -0.91% or -$0.46. The 52-week high for the MIRM share is $54.23, that puts it down -7.73 from that peak though still a striking 43.27% gain since the share price plummeted to a 52-week low of $28.56. The company’s market capitalization is $2.49B, and the average trade volume was 433.90K shares over the past three months.

Mirum Pharmaceuticals Inc (MIRM) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.10. MIRM has a Sell rating from 0 analyst(s) out of 9 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 9 recommend a Buy rating for it.

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) trade information

Mirum Pharmaceuticals Inc (MIRM) registered a -0.91% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.91% in intraday trading to $50.34, hitting a weekly high. The stock’s 5-day price performance is 2.69%, and it has moved by 11.03% in 30 days. Based on these gigs, the overall price performance for the year is 52.55%.

The consensus price target of analysts on Wall Street is $59.5, which implies an increase of 15.39% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $39 and $75 respectively. As a result, MIRM is trading at a discount of -48.99% off the target high and 22.53% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 4.14%. While earnings are projected to return 39.83% in 2025.

MIRM Dividends

Mirum Pharmaceuticals Inc is due to release its next quarterly earnings on 2025-May-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

The next largest institutional holding, with 4.99 million shares, is of JANUS HENDERSON GROUP PLC’s that is approximately 10.5615% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $170.56 million.